Levodropropizine

Levodropropizine
Systematic (IUPAC) name
	(2S)-3-(4-phenylpiperazin-1-yl)propane-1,2-diol
Clinical data
AHFS/Drugs.com	International Drug Names
Pregnancy cat.	?
Legal status	?
Pharmacokinetic data
Protein binding	11-14%
Excretion	83% via urine within 96 h
Identifiers
CAS number	99291-25-5
ATC code	R05DB27
PubChem	CID 65859
ChemSpider	59270
UNII	3O31P6T4G3
KEGG	D08119
Chemical data
Formula	C13H20N2O2
Mol. mass	236.31 g/mol
	SMILES O[C@@H](CN2CCN(c1ccccc1)CC2)CO;
	InChI InChI=1S/C13H20N2O2/c16-11-13(17)10-14-6-8-15(9-7-14)12-4-2-1-3-5-12/h1-5,13,16-17H,6-11H2/t13-/m0/s1 ; Key:PTVWPYVOOKLBCG-ZDUSSCGKSA-N ;
(what is this?) (verify);

Levodropropizine is a cough suppressant. It is the levo isomer of Dropropizine. It acts as a peripheral antitussive, with no action in the central nervous system. It does not cause side effects such as constipation or respiratory depression which can be produced by opioid antitussives such as codeine and its derivatives.

References [edit]

This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it.